Reliability of serum S100B measurement following mild traumatic brain injury: a comparison of assay measurements from two laboratories

: Grant L. Iverson, Jussi P. Posti , Juha Öhman , Kaj Blennow , Henrik Zetterberg, Teemu Miikka Luoto

Publisher: TAYLOR & FRANCIS LTD

: 2020

: Brain Injury

: BRAIN INJURY

: 34

: 9

: 1237

: 1244

: 8

: 0269-9052

: 1362-301X

DOI: https://doi.org/10.1080/02699052.2020.1800092

Objective There is enormous research and clinical interest in blood-based biomarkers of mild traumatic brain injury (MTBI) sustained in sports, daily life, or military service. We examined the reliability of a commercially available assay for S100B used on the same samples by two different laboratories separated by 2 years in time. Methods and Procedures A cohort of 163 adult patients (head CT-scanned, n = 110) with mild head injury were enrolled from the emergency department (ED). All had Glasgow Coma Scale scores of 14 or 15 in the ED (94.4% = 15). The mean time between injury and venous blood sampling was 2.9 h (SD = 1.4; Range = 0.5-6.0 h). Serum S100B was measured at two independent centers using the same high throughput clinical assay (Elecsys S100B (R); Roche Diagnostics). Results The Spearman correlation between the two assays in the total sample (N = 163) was r = 0.93. A Wilcoxson Signed Ranks test indicated that the median scores for the values differed (Z = 2,082,p< .001, Cohen's d = 0.151, small effect size). The values obtained from the two laboratories were very similar for identifying traumatic intracranial abnormalities (sensitivity = 80.1% versus 85.7%). Conclusions The serum S100B results measured using the same assay in different laboratories yielded highly correlated and clinically similar, but clearly not identical, results.